Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: Support for the role of the HPS gene product in intracellular trafficking

Laboratory Investigation

Volumn 78, Issue 9, 1998, Pages 1037-1048

  Boissy, Raymond E ^a   Zhao, Yang ^a   Gahl, William A ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPA; GENE PRODUCT; MELATONIN; MONOPHENOL MONOOXYGENASE;

ARTICLE; CASE REPORT; CELL TRANSPORT; GENE MUTATION; HUMAN; HUMAN CELL; HYPOPIGMENTATION; MELANOCYTE; OCULAR ALBINISM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SKIN BIOPSY;

ALBINISM, OCULOCUTANEOUS; ANTIGENS, CD; CELLS, CULTURED; GENE EXPRESSION; HUMANS; INTRACELLULAR MEMBRANES; MELANINS; MELANOCYTES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; MUTATION; OXIDOREDUCTASES; PLATELET MEMBRANE GLYCOPROTEINS; PROTEINS; TISSUE DISTRIBUTION;

EID: 0031716330     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Abdel-Malek Z, Swope VB, Pallas J, Krug K, and Nordlund JJ (1992). Mitogenic, melanogenic and cAMP responses of cultured neonatal human melanocytes to commonly used mitogens. J Cell Physiol 150:416-425.
2. Abdel-Malek Z, Swope V, Collins C, Boissy R, Zhao H, and Nordlund J (1993). Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes. J Cell Sci 106:1323-1331.
3. Bailin T, Oh J, Feng GH, Fukai K, and Spritz RA (1997). Organization and nucleotide sequence of the human Hermansky-Pudlak syndrome (HPS) gene. J Invest Dermatol 108:923-927.
4. Bednár B, Hermansky F, and Lojda Z (1964). Vascular pseudohemophilia associated with ceroid pigmentophagia in albinos. Am J Pathol 45:283-294.
5. Boissy RE (1998). Extracutaneous melanocytes. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, and Ortonne JP, editors: The pigmentary system: physiology and pathophysiology. New York: Oxford University Press, 59-73.
6. Chakraborty AK, Mishima Y, Inazu M, Hatta S, and Ichihashi M (1989). Melanogenic regulatory factors in coated vesicles from melanoma cells. J Invest Dermatol 93:616-620.
7. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidium thiocyanate, phenolchloroform extraction. Anal Biochem 162:156-159.
8. Colello RJ and Jeffery G (1991). Evaluation of the influence of optic stalk melanin on the chiasmatic pathways in the developing rodent visual system. J Comp Neurol 305:304-312.
9. Erickson RP (1997). Pigment, platelets, and Hermansky-Pudlak in human and mouse. Proc Natl Acad Sci USA 94:8924-8925.
10. Feng GH, Bailin T, Oh J, and Spritz RA (1997). Mouse pale ear (ep) is homologous to human Hermansky-Pudlak syndrome and contains a rare 'AT-AC' intron. Hum Mol Genet 6:793-797.
11. Frenk E and Lattion F (1982). The melanin pigmentary disorder in a family with Hermansky-Pudlak syndrome. J Invest Dermatol 78:141-143.
12. Fukai K, Oh J, Frenk E, Almodovar C, and Spritz RA (1995). Linkage disequilibrium mapping of the gene for Hermansky-Pudlak syndrome to chromosome 10q23.1-q23.3. Hum Mol Genet 4:1665-1669.
13. Gahl WA, Brantly M, Kaiser-Kupfer MI, Iwata F, Hazelwood S, Shotelersuk V, Duffy LF, Kuehl EM, Troendle I, and Bernardini I (1998). Clinical characteristics of Hermansky-Pudlak syndrome in patients with and without the Puerto-Rican 16-BP HPS gene duplication. N Engl J Med 338:1258-1264.
14. Garay SM, Gardella JE, Fazzini EP, and Goldring RM (1979). Hermansky-Pudlak syndrome; pulmonary manifestations of a ceroid storage disorder. Am J Med 66:737-747.
15. Gardner JM, Wildenberg SC, Keiper NM, Novak EK, Rusiniak ME, Swank RT, Puri N, Finger JN, Hagiwara N, Lehman AL, Gales TL, Bayer ME, King RA, and Brilliant MH (1997). The mouse pale ear (ep) mutation is the homologue of human Hermansky-Pudlak syndrome. Proc Natl Acad Sci USA 94: 9238-9243.
16. Gerrard JM, Lint D, Sims PJ, WiedmerT, Fugate RD, McMillan E, Robertson C, and Israels SJ (1991). Identification of a platelet dense granule membrane protein that is deficient in a patient with the Hermansky-Pudlak syndrome. Blood 77: 101-112.
17. Gilchrest BA, Park H-Y, Eller MS, and Yaar M (1998). The photobiology of the tanning response. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, and Ortonne J-P, editors: The pigmentary system: physiology and pathophysiology. New York: Oxford University Press, 359-372.
18. Guillery RW (1974). Visual pathways in albinos. Sci Am 230:44-55.
19. Halaban R and Alfano FD (1984). Selective elimination of fibroblasts from cultures of normal human melanocytes. In Vitro Cell Dev Biol 20:447-450.
20. Harmon KR, Witkop CJ, White JG, King RA, Peterson M, Moore D, Tashjian J, Marinelli WA, and Bitterman PB (1994). Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome. J Lab Clin Med 123:617-627.
21. Hay JC and Scheller RH (1997). SNAREs and NSF in targeted membrane fusion. Curr Opin Cell Biol 9:505-512.
22. Hazelwood S, Shotelesuk V, Wildenberg SC, Chen D, Iwata F, Kaiser-Kupfer MI, White JG, King RA, and Gahl WA (1997). Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome. Am J Hum Genet 61:1088-1094.
23. Hermansky F and Pudlak P (1959). Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: Report of two cases with histochemical studies. Blood 14:162-169.
24. Jimbow K and Sugiyama S (1998). Melanosomal translocation and transfer. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, and Ortonne J-P, editors: The pigmentary system: physiology and pathophysiology. New York: Oxford University Press, 107-114.
25. Karnovsky MJ (1965). A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy (abstract). J Cell Biol 27:137.
26. Karnovsky MJ (1971). Use of ferrocyanide-reduced oximum tetroxide in electron microscopy (abstract). J Cell Biol 51: 146.
27. Medrano EE and Nordlund JJ (1990). Successful culture of adult human melanocytes from normal and vitiligo donors. J Invest Dermatol 95:441-445.
28. Norris DA, Morelli JG, and Fujita M (1998). Melanocyte interactions in the skin. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, and Ortonne J-P, editors: The pigmentary system: physiology and pathophysiology. New York: Oxford University Press, 123-133.
29. Novikoff A, Albala A, and Biempica L (1968). Ultrastructural and cytochemical observations on B16 and Harding-Passey melanomas. The origin of premelanosomes and compound melanosomes. J Histochem Cytochem 16:299-319.
30. Oh J, Bailin T, Fukai K, Feng GH, Ho L, Mao J, Frenk E, Tamura N, and Spritz RA (1996). Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet 14:300-306.
31. 1 and Quin 2 AM induced platelet dysfunction. Restoration of function by norepinephrine. Prostaglandins Leukot Essent Fatty Acids 39:141-146.
32. Rothman JE and Wieland FT (1996). Protein sorting by transport vesicles. Science 272:227-234.
33. Schinella RA, Greco MA, Cobert BL, Denmark LW, and Cox RP (1980). Hermansky-Pudlak syndrome with granulomatous colitis. Ann Intern Med 92:20-23.
34. Seiji M, Fitzpatrick TB, and Birbeck MSC (1961). The melanosome: a distinctive subcellular particle of mammalian melanocytes and the site of melanogenesis. J Invest Dermatol 36:243-252.
35. Shibahara S, Yasumoto K-I, and Takahashi K (1998). Genetic regulation of the pigment cell. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, and Ortonne J-P, editors: The pigmentary system: physiology and pathophysiology. New York: Oxford University Press, 251-273.
36. Shotelersuk V, Larson D, Hazelwood S, Iwata F, Kaiser-Kupfer MI, Kuehl E, Bernardini I, and Gahl WA (1998). Three new mutations in a gene causing Hermansky-Pudlak syndrome: clinical correlations. Mol Genet Metab in press.
37. Simon JW, Adams RJ, Calhoun JH, Shapiro SS, and Ingerman CM (1982). Ophthalmic manifestations of the Hermansky-Pudlak syndrome (oculocutaneous albinism and hemorrhagic diathesis). Am J Ophthalmol 93:71-77.
38. Summers CG, Knobloch WH, Witkop CJ, and King RA (1988). Hermansky-Pudlak syndrome: Ophthalmic findings. Ophthalmology 95:545-554.
39. Szabó G, Gerald AB, Pathak MA, and Fitzpatrick TB (1969). Racial differences in the fate of melanosomes in human epidermis. Nature 222:1081-1082.
40. Terrian DM and White MK (1997). Phylogenetic analysis of membrane trafficking proteins: a family reunion and secondary structure predictions. Eur J Cell Biol 73:198-204.
41. Weiss HJ, Lages B, Vicic W, Tsung LY, and White JG (1993). Heterogeneous abnormalities of platelet dense granule ultrastructure in 20 patients with congenital storage pool deficiency. Br J Haematol 83:282-295.
42. White JG, Edson JR, Desnick SJ, and Witkop CJ Jr (1971). Studies of platelets in a variant of the Hermansky-Pudlak syndrome. Am J Pathol 63:319-332.
43. Wildenberg SC, Oetting WS, Almodóvar C, Krumwiede M, White JG, and King RA (1995). A gene causing Hermansky-Pudlak syndrome in a Puerto Rican population maps to chromosome 10q2. Am J Hum Genet 57:755-765.
44. Witkop CJ Jr, Hill CW, Desnick S, Thies JK, Thorn HL, Jenkins M, and White JG (1973). Ophthalmologic, biochemical, platelet, and ultrastructural defects in the various types of oculocutaneous albinism. J Invest Dermatol 60:443-456.
45. Witkop CJ Jr, Quevedo WC Jr, Fitzpatrick TB, and King RA (1989). Albinism. In: Scriver CR, Beaudet AL, Sly WS, and Valle D, editors: The metabolic basis of inherited disease. 6th ed. vol 2. New York: McGraw-Hill, 2905-2947.
46. Yamamoto O and Bhawan J (1994). Three modes of melanosome transfers in Caucasian facial skin: hypothesis based on an ultrastructural study. Pigment Cell Res 7:158-169.
47. Zhao H, Boissy Y, Abdel-Malek Z, King RA, Nordlund JJ, and Boissy RE (1994). On the analysis of the pathophysiology of Chediak-Higashi syndrome: Defects expressed by cultured melanocytes. Lab Invest 71:25-34.
48. Zhou B-K, Boissy RE, Pifko-Hirst S, Moran DJ, and Orlow SJ (1993). Lysosome-associated membrane protein-1 (LAMP-1) is the melanocyte vesicular membrane glycoprotein, Band II. J Invest Dermatol 100:110-114